Journal of Nuclear Medicine Technology December 2025, jnmt.125.270843; DOI: https://doi.org/10.2967/jnmt.125.270843 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271145; DOI: https://doi.org/10.2967/jnmt.125.271145 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271119; DOI: https://doi.org/10.2967/jnmt.125.271119 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.270227; DOI: https://doi.org/10.2967/jnmt.125.270227 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...
Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...
Radioligand therapy (RLT) is a recent term for long established nuclear medicine practices. Although radioiodine provides the historical foundations of theranostics, the prototype RLTs include ...
The widespread success of 177Lu-PSMA-617 for prostate cancer has generated unprecedented volume in theranostics. Prostate-specific membrane antigen–targeted theranostics is possibly the most complex ...
The recent reinvigoration of theranostics comes with advances in computing technology, radiochemistry, and instrumentation that synergize with developments in artificial intelligence (AI). There is a ...
Technologists are increasingly responsible for complex theranostic procedures, yet formal training and standardized protocols ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback